news

In order to explore the international market and build a platform for international exchange and cooperation, Heron (Shanghai) will participate in the exhibition with APIs developed and produced by its parent company Nanjing Heron (booth No.: 80Q20).

CPHI Worldwide will be held in Barcelona, Spain on October 24-26, 2023. As the world's largest pharmaceutical raw materials exhibition, CPHI Worldwide has been successfully held for 30 sessions, and has been actively participated in and widely recognized by the world's pharmaceutical raw materials industry practitioners. At present, CPHI Worldwide has become a professional platform for the global pharmaceutical industry to carry out trade promotion and information exchange, and also plays a weathervane role in the development direction of the entire pharmaceutical industry.

Founded in 2013, Heron Pharma is a pharmaceutical company adhering to an innovation-driven and product differentiation strategy. It possesses world-leading research and development technology for active vitamin D derivatives, NCEs and first generics. The bulk production of active vitamin D derivative drugs can be provided with diverse DMFs over the world, including Alfacalcidol, calcipotriol, Paricalcitol,Tacalcitol etc.

Heron (Shanghai) Pharmaceutical Science & Technology Co., Ltd. sincerely invites you to our booth to discuss potential business collaborations.